Ivan Klíma
Czech playwright, publicist, bookwriter and university educator
Ivan Klíma's AcademicInfluence.com Rankings
Download Badge
Literature
Why Is Ivan Klíma Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ivan Klíma is a Czech novelist and playwright. He has received the Magnesia Litera award and the Franz Kafka Prize, among other honors. Biography Klíma's early childhood in Prague was happy and uneventful, but this all changed with the German invasion of Czechoslovakia in 1938, after the Munich Agreement. He had been unaware that both his parents had Jewish ancestry; neither were observant Jews, but this was immaterial to the Germans.
Ivan Klíma's Published Works
Published Works
- Osteopontin: possible role in prostate cancer progression. (1999) (281)
- Patient-derived xenografts and organoids model therapy response in prostate cancer (2020) (43)
- miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo (2019) (34)
- Abnormal p53 expression is rare in clinically localized human prostate cancer: Comparison between immunohistochemical and molecular detection of p53 mutations (1997) (30)
- CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma (2018) (28)
- Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression (2008) (19)
- Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity (2020) (15)
- Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955. (2004) (15)
- Can the reverse transcriptase‐polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen improve staging and predict biochemical recurrence? (2002) (12)
- Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer (2019) (11)
- Scavenger receptor block as strategy for the identification of bone marrow homing phages by panning in vivo random peptide phage displayed libraries. (2002) (9)
- ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models (2017) (7)
- Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures (2020) (7)
- Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth. (2006) (6)
- Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy (2022) (2)
- 454 Potential chemopreventive agents and PSA expression in the LNCAP model of human prostate cancer progression (2004) (2)
- Stroma transcriptomic and proteomic profile of prostate cancer metastasis xenograft models reveals conservation of bone microenvironment signatures (2020) (1)
- Bladder cancer organoids as a functional system to model different disease stages and therapy response (2022) (1)
- A novel strategy for the identification by phage panning in vivo of ligands specific for cells in the extra-vascular space (2001) (1)
- NOGGIN BLOCKS OSTEOSCLEROSIS IN PROSTATE CANCER BONE METASTASIS (2006) (0)
- Effect of MCAM on the aggressive phenotype in human prostate cancer. (2017) (0)
- Effects of ALK1Fc treatment on prostate cancer cells interacting with bone and bone cells in bone metastasis models. (2017) (0)
- Abstract B18: Patient-derived xenograft and organoids models of prostate cancer (2020) (0)
- 417: Downregulation of the Tumor Suppressor Gene TGF-Beta-Stimulated Clone 22 (TSC-22) in Human Prostate Cancer (2004) (0)
- miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo (2019) (0)
- Establishment of an androgen-sensitive patient derived xenograft model of prostate cancer (2019) (0)
- PD59-07 PERSONALISED ORGANOID DRUG TREATMENT AND THERAPY RESISTANCE ON NOVEL EARLY ONSET METASTASIS XENOGRAFT MODEL (2020) (0)
- 453 HMSH2 expression analysis in tumour tissue microarray predicts outcome and survival of patients with prostate cancer (2004) (0)
- 159 The tumour suppressor gene TSC-22 (transforming growth factor-beta-stimulated clone 22) MRNA-expression is downregulated in prostate cancer cell lines (2004) (0)
- Expression of BMP antagonists in cancer cells inducing osteolytic or osteoclerotic bone metastases (2003) (0)
- 797: Noggin Blocks the Osteoinductive Properties of Human Prostate Cancer Cell Lines (2006) (0)
- 154 Profiling the TGF-beta superfamily in human prostate cancer: Downregulation of the tumour suppressor gene TSC-22 (transforming growth factor-beta-stimulated clone 22) (2004) (0)
- OP1-06 IN MOLECULAR DETECTION OF OCCULT LYMPH NODE METASTASES EPITHELIAL MARKERS ARE HERE TO STAY (2014) (0)
- MCAM supports the aggressive phenotype in human prostate cancer (2017) (0)
- Can Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for Prostate Specific Antigen (PSA) and Prostate Membrane Specific Antigen (PMSA) improve staging and predict biochemical recurrence? (2002) (0)
- Patient-derived organoids as a promising preclinical model for assessing therapy response in bladder cancer (2023) (0)
- Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity (2021) (0)
- Personalised organoid drug treatment and therapy resistance characterization based on novel BRCA2 prostate cancer xenograft of SPOP-like phenotype and microsatellite instability (2020) (0)
- Characterization and personalized treatment response in primary and metastatic prostate canceroids (2017) (0)
- Osteopontin : Possible Role in Prostate Cancer Progression 1 (1999) (0)
- PATIENT DERIVED XENOGRAFTS AS PRECLINICAL MODELS OF UROLOGICAL MALIGNANCIES: MP44‐17 (2017) (0)
- Abstract 3885: Establishment, characterization and drug response of primary and metastatic prostate organoids (2017) (0)
- 881Modulation of osteoinductive properties of human cancer cell lines: Essential role of noggin (2005) (0)
- MCAM SUPPORTS THE AGGRESSIVE PHENOTYPE IN HUMAN PROSTATE CANCER: PD33‐06 (2017) (0)
- Bone morphogenetic protein-7 (BMP-7) is downregulated in prostate cancer (2003) (0)
- The tumor suppresor gene TSC-22 (transforming growth factor-beta-stimulated clone 22) mRNA-expression is downregulated in prostate cancer (2003) (0)
- Prostate Cancer: Basic Research & Pathophysiology IPD33-06 MCAM SUPPORTS THE AGGRESSIVE PHENOTYPE IN HUMAN PROSTATE CANCER (2017) (0)
- MODELLING PROSTATE CANCER USING PRIMARY AND METASTATIC CANCEROIDS: MP41‐10 (2017) (0)
- 892Expression, regulation and in vivo growth inhibition by transforming growth factor-β (TGFO) stimulated clone-22 (TSC-22) in prostate cancer (2005) (0)
- ALK1Fc suppresses tumor growth by impairing proliferation of human prostate cancer cells in vitro and in vivo (2017) (0)
- Abstract 4344: Cd146 modulates the malignant phenotype in human prostate cancer (2017) (0)
This paper list is powered by the following services:
Other Resources About Ivan Klíma
What Schools Are Affiliated With Ivan Klíma?
Ivan Klíma is affiliated with the following schools:
What Are Ivan Klíma's Academic Contributions?
Ivan Klíma is most known for their academic work in the field of literature. They are also known for their academic work in the fields of
Ivan Klíma has made the following academic contributions: